After congenital, perinatal, or early postnatal infection, the virus may linger for years in body fluids. Sources of CMV infection in transplant recipients include latent reactivation, donor ...
A bivalent DNA vaccine (pp65 and gB) induces gB-specific neutralizing antibodies and virus-specific CTL responses in a murine model. It also induces antibody and T-cell immunity in CMV ...